Connect with us

Finance

Senate Finance Committee Releases Excoriating Investigation of Abuse in At-Risk Youth Industry

Published

on

Senate Finance Committee Releases Excoriating Investigation of Abuse in At-Risk Youth Industry

After years of facing criticism for wrongdoing and mistreatment of patients, the at-risk youth industry was blasted in a report released on Wednesday by the U.S. Senate Finance Committee.

The report and communications from the committee chairman, Sen. Ron Wyden (D-Ore.), conclude that systemic harm and abuse are “routine” parts of the at-risk youth industry. It delves into specific incidents at facilities owned and/or operated by some of the industry’s most prominent players: Universal Health Services (NYSE: UHS), Acadia Healthcare Co. Inc. (Nasdaq: ACHC), Devereux Advanced Behavioral Health and Vivant Behavioral Healthcare.

“The harms, abuses, and indignities children in [residential treatment facilities] have experienced and continue to experience today occur inevitably and by design: they are the direct causal result of a business model that has incentive to treat children as payouts and provide less than adequate safety and behavioral health treatment in order to maximize operating and profit margin,” the report states.

The presentation of the report also enlisted the support of socialite and media personality Paris Hilton, a staunch critic and self-described survivor of the at-risk youth industry. The Senate Finance Committee also hosted a hearing on Wednesday to discuss the report’s findings.

Hilton, Wyden, the report itself and several others call on Congress to act.

Advertisement

“Providers will continue to operate this model because it’s good business, unless there is some bold intervention,” the report states.

Wyden’s Republican counterpart, Senate Finance Committee Ranking Member Mike Crapo, also called for reforms. In a statement, Crapo said that the report’s findings were “deeply disturbing” and that “chronic patterns of failure must not go unnoticed or unaddressed.” 

The report finds that understaffing, restraints (both physical and chemical), poor care and a general lack of oversight within and of residential treatment facilities were typical for the industry.

The action contemplated by the report and the Senate Finance Committee centers on elevated scrutiny of the industry and the role of government payers supporting these operations. The report and proceedings focus on what they call residential treatment facilities, which focus on providing care to children on a long-term basis.

The Senate Finance Committee report’s recommendations are summarized into three points: ensuring safe and dignified treatment in home-like settings, government prioritization of community-based services and more effective oversight of standards of and funding for facilities. These three specific recommendations should be taken up by Congress, the report states.

Advertisement

It calls on state governments to use existing authority to favor community-based services, calling many states’ historic reliance on residential treatment facilities inappropriate, and to “ramp up their oversight capabilities for youth in both in-state and out-of-state facilities.”

The report also calls on the U.S. Department of Justice to enforce Title II of the Americans with Disabilities Act to ensure that violations of so-called “Olmstead” standards are addressed within the at-risk youth industry. These provisions require that people be treated for severe conditions in the least restrictive setting possible.

“After reading it (the report), I honestly have never felt so seen and heard: it validates everything that I’ve been fighting for over the past four years,” Hilton said in a video statement released Wednesday morning. “As a survivor, please do something. I am begging you to protect your constituents before it’s too late.”

The committee meeting featured subject matter experts who testified before the Senate Finance Committee. Wyden said during his prepared remarks that Marc Miller, the CEO of UHS, was invited to participate in the meeting and that UHS was invited to engage with the committee’s investigators. UHS and Miller declined to do so; Miller was listed as a witness in notices for the meeting but did not attend.

On top of the recent public pillorying, Acadia Healthcare and UHS have seen substantial financial ramifications for abuses recognized by the courts at their facilities.

Advertisement

In July 2023, a jury ruled against Acadia Healthcare in a civil lawsuit involving sexual abuse of a minor at a now-defunct facility that totaled $405 million. In October 2023, Acadia agreed to pay $400 million to settle three cases related to abuse at the facility.

In April, a court ruled against UHS to the tune of $535 million over an incident involving a child sexually abusing another child at a facility in Champaign, Illinois.

The report adds what some call “headline risk” to a modality of care that is replacing wilderness therapy. For example, Chandler, Arizona-based Embark Behavioral Health, a sizable care provider in the at-risk youth segment, is abandoning wilderness therapy altogether in hopes of transitioning these businesses into residential treatment facilities and investing more in outpatient offerings.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Finance

Tech trade needs 2 things to remain 'in favor' this year

Published

on

Tech trade needs 2 things to remain 'in favor' this year
MJP Wealth Advisors chief investment officer Brian Vendig sits down with Morning Brief host Julie Hyman to discuss the tech trade’s (XLK) outlook for 2026. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.
Continue Reading

Finance

Promising UK Penny Stocks To Watch In January 2026

Published

on

Promising UK Penny Stocks To Watch In January 2026
The UK market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting global economic interdependencies. Despite these broader market pressures, investors may find intriguing opportunities in penny stocks—smaller or newer companies that can offer a mix of affordability and growth potential. While the term ‘penny stocks’ might seem outdated, their potential remains significant for those seeking financial strength and…
Continue Reading

Finance

Why Chime Financial Stock Was Music to Investor Ears in December | The Motley Fool

Published

on

Why Chime Financial Stock Was Music to Investor Ears in December | The Motley Fool

The company appears to be effectively serving its often-overlooked customer base.

The holiday month brought fintech Chime Financial (CHYM 3.13%) one of the best gifts a stock can receive — a substantial bump higher in price. Across December, Chime’s shares rose by more than 19%, lifted by a set of factors that included a recommendation upgrade from a prominent bank and a positive research note by an analyst who’s now tracking the company.

Good as gold

The bullish tone was set by that upgrade, which was made before market open on Dec. 1 by Goldman Sachs pundit Will Nance. According to his new evaluation, Chime stock is now a buy, up from Nance’s previous tag of neutral. The new price target is $27 per share.

Image source: Getty Images.

According to reports, the analyst’s move is based on the company’s new Chime Card, an innovative credit product that represents an evolution of the secured credit card (i.e., plastic that must be backed by a user’s actual funds).

Advertisement

In Nance’s estimation, as a next-generation credit product, the Chime Card should earn more “take” (i.e., fees derived from use) and thus higher revenue and profitability for the company than many anticipate. The prognosticator wrote that “attach” rates — i.e., Chime customer uptake — could also be notably above current expectations.

On Dec. 11, a new Chime bull emerged. This is B. Riley analyst Hal Goetsch, who initiated coverage of the company’s stock with a buy recommendation. This was accompanied by a price target of $35 per share, which is well higher than even Nance’s very optimistic assessment.

Goetsch waxed bullish about Chime’s high growth potential, according to reports. He opined that the company is doing well servicing its target segment of customers traditionally shunned by established banks due to poor credit histories, among other perceived flaws. It has also cleverly partnered with lenders and other financial services providers to offer attractive products such as the Chime Card.

Chime Financial Stock Quote

Today’s Change

(-3.13%) $-0.87

Current Price

Advertisement

$26.95

Executive shifts

Finally, Chime promoted no less than three of its executives to new positions. It announced in the middle of the month that former chief operating officer Mark Troughton had been named president, and Janelle Sallenave replaced him as chief operating officer (from chief experience officer). Vineet Mehra, meanwhile, became chief growth officer; previously, he was chief marketing officer.

All three appointments, announced in the middle of the month, were effective immediately.

Advertisement

As the year came to a close, it was apparent that the company had executives who were eager to keep contributing to its success. That, combined with those bullish analyst notes and the somewhat under-the-radar success story that the Chime Card appears to be, makes this fintech’s stock well worth watching. This is one of the more innovative young businesses in the financial sector at present.

Continue Reading

Trending